QIAGEN OmicSoft and Biomedical Knowledge Base
Assessing drug safety with QIAGEN Biomedical KB-AI
207 views
Are you a healthcare professional, clinical researcher or data scientist interested in drug safety research? If so, you know how vital understanding a drug’s adverse effects is to maximize its effect while minimizing its risks. This webinar will show how the QIAGEN Biomedical KB-AI knowledge graph can be used to explore scientific and pharmacovigilance data. Focusing on immune checkpoint inhibitors (ICIs), we will also demonstrate how Neo4j and Python can be combined to query, visualize and analyze this data effectively.
We’ll cover the following:
• Drug safety profiling in Biomedical KB-AI
• Pharmacovigilance case study of ICIs: Pembrolizumab
• Comparative analysis of ICIs for comprehensive safety monitoring.
Related videos
QIAGEN OmicSoft and Biomedical Knowledge Base
Knowledge graphs and more: Analytics-driven drug discovery using advanced biomedical...
High-quality biomedical relationships knowledge is the cornerstone of modern...
QIAGEN OmicSoft and Biomedical Knowledge Base
Supercharge your AI in drug discovery with high-quality biomedical data
If you’re working in pharma or biotech, you likely rely on artificial...
QIAGEN OmicSoft and Biomedical Knowledge Base
Unlocking the power of API-based 'omics queries
If you're a data scientist or bioinformatician working in biopharma, here's...
QIAGEN OmicSoft and Biomedical Knowledge Base
Integrating deeply curated omics data with APIs for biomarkers and drug-target investigation
If you’re a data scientist or bioinformatician working in biopharma and need...